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Introduction
Impaired healing of war wounds remains an unsolved military medical problem. It involves complex interactions between cell types, matrix and soluble mediators. In sepsis which is often associated with war wounds, one or more of these components is disrupted. One of the key elements in wound repair is the release of growth factors (e.g. EGF, PDGF, FGF-1, VEGF, KGF-1), which bind to specific receptors on the target cell and activate signal transduction pathways that finally result in proliferation, migration or synthesis of structural elements. There has been some success with topical application of growth factors to improve healing in the face of sepsis and infection (1) (2) (3) . However the effects have been modest. A major limitation of topical application of growth factors is that they are destroyed rapidly by tissue proteases. The gene therapy approach we propose will have the advantage of continually producing growth factors within the wound to constantly replenish tissue levels. We are testing this approach using electroporation (EP) to deliver growth factor plasmid DNA to a rodent war wound model.
Body
Describe the research accomplishments associated with each task outlined in the approved Statement of Work.
Refined animal model of sepsis.
The originally proposed method of inducing sepsis using E. Coli-impregnated agar pellets to model a war wound in the rat resulted in a high mortality. We identified a suitable model with a mortality rate of less than 10% and a profound effect on wound healing. The useful model is complete cecal ligation with feces in the cecum. This preparation produces significant, but survivable peritonitis, which would be a common clinical scenario for a military casualty who sustained an abdominal injury.
Optimized EP parameters and dosage regimens.
We assessed the ability of in vivo electroporation to enhance cutaneous transfection of naked plasmid DNA. A luciferase encoding plasmid driven by a CMV promoter was injected at the wound border. Following plasmid administration, electroporative pulses were applied to injection sites. Luciferase expression in animals was analyzed using an in vivo luciferase imaging system. Pulse parameters were varied over arrange of voltage, duration, and number. The electroporative effect was most marked at a plasmid dose of 50 jig, where an approximate 10-fold increase was seen. Six 100 [ts duration pulses of 1750V/cm were found to be the most effective in increasing luciferase activity ( Figure 7A of Byrnes et al). Higher voltages than 1800 V/cm tended to either cause arcing of the electric pulse between the electrodes or left some signs of an electrical bum on the animal's skin. Double EP (two applications of EP-assisted transfection separated by 24 hours) did not produce significantly different luciferase expression when compared to single EP ( Figure 4 of Lin et al).
We then compared the luciferase plasmid transfection with and without EP using the optimized EP regimen. EP effectively increased expression of luciferase plasmid up to 53-fold compared to vector without EP on day 5 (p<0.001, Figure 2 
and 3 of Lin et al).
The increased activity was maintained for an interval of three weeks, which is appropriate for treatment of wound healing ( Figure 4 of Byrnes et al). In addition, transfection was predominately localized to the epithelium, and did not extend into the musculature of the carcass, when plasmid injection and EP were applied to the skin with skin specific parameters ( Figure 6 of Lin et al).
3. Demonstrated improvement in wound healing with EP-assisted keratinocyte growth factor-i (KGF-1) transfection We measured both the wound areas and wound breaking strength at day 7 in animals with and without the administration of the most effective electroporation settings (6 x 100 jts, 1750 V/cm). EP showed no detrimental effect on these healing parameters. In fact, there was a slight non-significant tendency for the electroporated wounds to have improved healing as evidenced by a smaller open area and greater tensile strength ( Figure 9A and B of Byrnes et al).
We then assessed the ability of the PCDNA3.1/KGF-1 expression vector to improve cutaneous wound healing in the septic rat model. The rate of wound healing was impaired by partial cecal ligation to induce sepsis. Average wound area was 4.7 times larger on day 9 in septic rats compared to control (p<0.001, Figure 1 of Lin et al). The rate of wound healing improved with KGF-1 expression vector and EP. Wounds were 60% smaller on day 12 versus vector without EP (p<0.009, Figure 7 of Lin et al). In addition, the quality of healing was assessed histologically using a point scale from 1-4 ( Figure 8 of Lin et al). The quality of healing using KGF-1 vector with EP was scored 3.0 +/-0.3 and was significantly better than that of 1.8 +/-0.3 for treatment with vector alone (p<0.05, Figure 9 of Lin et al).
With the positive effect on wound quality noted histologically, we did not perform collagen assays. Disappointingly, multiple growth factors do not improve wound closure as compared to KGF-l alone.
Key Research Accomplishments
"• E. coli impregnated agar pellets and cecal ligation to model sepsis was changed to model with cecal ligation only because of high mortality rate in previous model. "* Voltage of 1800 was required to increase the transfection efficiency of the luciferase reporter gene into the rat model; a single application of plasmid was just as effective as a double dose of plasmid "* EP increased luciferase vector transfection efficiency 53-fold as compared to nonelectroporated controls "* Luciferase vector expression was predominately localized in the epithelium when injected intradermally with EP administration "* EP alone showed no detrimental effect on healing parameters, such as wound areas and wound breaking strength "* EP-assisted KGF-1 plasmid DNA improved wound closure and quality of healing as compared to KGF-1 alone Transfection of wounds with DNA-encoding growth factors has the potential to Improve healing, but current means of nonviral gene delivery are inefficient. Repeated high doses of DNA, necessary to achieve reliable gene expression, are detrimental to healing. We assessed the ability of In vivo electroporation to enhance gene expression. Full-thickness cutaneous excisional wounds were created on the dorsum of female mice. A luciferaseencoding plasmid driven by a CMV promoter was injected at the wound border. Following plasmid administration, electroporative pulses were applied to injection sites. Pulse parameters were varied over a range of voltage, duration, and number. Animals were euthanized at intervals after transfection and the luciferase activity measured. Application of electric pulses consistently increased luciferase expression. The electroporative effect was most marked at a plasmid dose of 50 pg, where an approximate tenfold increase was seen, Six 100-psduration pulses of 1750 V/cm were found to be the most effective in increasing luciferase activity. High numbers of pulses tended to be less effective than smaller numbers. This optimal electroporation regimen had no detrimental effect on wound healing. We conclude that electroporation increases the efficiency of transgene expression and may have a role In gene therapy to enhance wound healing. Exogenous application of growth factors has been shown to have the potential to improve wound heal-PEI Polyethylenimine ing.1-3 However, the requirement for frequent dosing because of the short half-life of delivered peptides has rage healing. The skin is an attractive potential target limited their clinical efficacy. Gene therapy with for gene therapy due to its accessibility for application growth factor-encoding DNA may allow the continuous and monitoring and the possibility of removing tissue if production of these factors within wounds to encounecessary. 4 Although virally mediated gene delivery has a high transfection efficiency, there are serious concerns about its safety and potential pathogenicity.! However, The applied electrical field increases transmembrane voltage potential, exceeding membrane dielectric Electroporation strength and causing membrane defects through Animals were electroporated at the site of injection which the charged polynucleotide may pass.9 The elecwithin 2 minutes of plasmid administration, using a trophoretic effect of the field may also enhance DNA square wave electroporator (ECM 830, BTX Genetromigration within tissues.' 0 In vivo electroporation has nics, San Diego, CA). A custom designed pin electrode, been used to increase intracellular delivery of agents consisting of two 10-mm rows of parallel needles sepsuch as chemotherapeutics, both directly into tumors arated by 5 min was used to apply the electroporation and also to enhance transdermal drug delivery.9 Although voltage ( Figure 1 ). Between 6 and 18 square wave most commonly used for in vitro transfection applicapulses were administered, at an amplitude of between tions, electroporation has been of benefit in in vivo 400 and 1800 V, a duration of between 100 ýs to 20 ms, settings as well. Improvements in the transfection of and an interval between pulses of 125 ms ( Figure 2 ). 
From the Section of Surgical
MATERIALS AND METHODS
Luciferase substrate (100 pl) was added and the photon Female 6-to 8-week-old BALB-c mice were obtained emission measured over the following 10 seconds. from Jackson Laboratories (Bar Harbor, ME). All
The protein concentration of each sample was procedures were approved by the Johns Hopkins determined using a protein assay kit (Bio-Rad LaboraUniversity Animal Care and Use Committee.
tories, Hercules, CA). Light output was normalized to each sample's protein concentration and luciferase Plasmid preparations activity expressed as RLU/tg protein. The plasmid gWIZ-Lux, containing a CMV promoter and luciferase transgene, was obtained from Gene Therapy
In vivo luciferase imaging Systems (San Diego, CA). Plasmids were purified using
To assess the time course of luciferase expression with an endotoxin-free plasmid purification kit (Qiagen, and without electroporation, animals were analyzed Santa Clarita, CA) following culture in transformed using an in vivo luciferase imaging system. In these DH-5a bacteria. Plasmids were stored at -70 'C at a experiments, mice were wounded and injected with concentration of 2 mg/mil until used.
plasmid as previously described, but only the injection sites on the right side of each animal were electroPlasmid administration porated using six 100 ps pulses of 1750V/cm, with an Animals were anesthetized with an intraperitoneal interval of 125is. template with the wound at the midpoint. Each strip At time points after the initial transfection, animals was loaded onto a custom built tensiometer and tracwere sedated with intraperitoneal Avertin, and then tion applied at a rate of 10 mm/minute until complete injected intraperitoneally with 150 mg/kg of D-luciferin disruption of the wound occurred. The wound burst in water. After a conventional light photograph was strength was recorded in Newtons as the peak force taken, bioluminescent images were acquired using a across the tissue prior to fracture. cooled charged coupled device camera (MIS, Xenogen, Alameda, CA). Luminescent images were taken at intervals of between 10 and 40 minutes following luciferin sts analysis administration, during which time the light emission had been shown to be in a plateau phase. Bioluminesin means between groups were analyzed for significent images were overlaid onto the conventional image cance using Student's t-test or ANOVA as appropriate. of each animal, and the light emission, corrected for background luminescence, was calculated for each injection site using image analysis software (Living
RESULTS
Image, Xenogen). The different spectral colors repre-
There was no evidence of luciferase activity in uninsent a linear scale of the intensity of luminescence, jected skin tissue sites. Enzymatic activity was corresponding to the total number of photons emitted detected at plasmid dosages as low as 0.1 gg plasmid. per second from a square cm of tissue ( Figure 3 ).
Increasing the dosage of plasmid injected caused the Activities are expressed as total photons per second amount of luciferase activity to rise across the 500-fold for equal-sized regions of interest at the injection sites range tested up to 50 jtg ( Figure 5 ). are shown graphically ( Figure 4 ).
Lipofection and polyfection Wound healing measurements
The addition of Lipofectamine (80 pl/ml), DMRIE Animals were anesthetized and wounded as before. No (120 pl/ml), or PEI (5: 1 ratio of PEI-Nitrogen: plasmid was administered, and half the wounds were DNA-Phosphate) to plasmid solutions consistently reduced or abolished the luciferase activity seen in the skin tissue with 10 pg naked plasmid injection
2.E+08-
. compared to the unelectroporated group (n = 4 animals per Images were taken on days 1, 7, and 14.
group).
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0oo,ooo voltage electroporation parameters caused a 20-fold "increase in transfection efficiency ( Figure 7D Using the optimal electroporation parameters, the .E 20,000 electroporative effect was seen over a range of plasmid doses tested, but was most effective at higher doses of ( Figure 6 ). The highest luciferase activity was always Duration of transfection evident in animals injected with naked plasmid, withElectroporation of the skin tissue consistently led to an out either lipofection or polyfection.
increase in the transfection efficiency after a single injection of plasmid ( Figure 3 ). In order to examine if electroporation had any effect on the duration of gene Electroporation parameters expression, animals were imaged at varying intervals The application of electric pulses locally to the injecafter a single plasmid injection, between 1 day and 3 tion site consistently increased the transfection effiweeks ( Figure 4 ). The luciferase activity was approxiciency when measured at 24hours postinjection.
mately tenfold higher (7.71 x 106 ± 5.24 x 106 vs. 6.82 Increasing the applied voltage across the injected x 10 7 ± 2.28 x 107, p < 0.01 at day 1) in the electropotissue caused an increase in the luciferase activity rated injection sites than in the nonelectroporated ( Figure 7A ). This effect was most apparent at higher sites. This increased activity was maintained throughplasmid doses where the increase was over tenfold.
out the duration of the experiment, up to an interval of Higher voltages than 1800 V/cm tended to either cause 3 weeks. arcing of the electric pulse between the electrodes or left some signs of an electrical burn on the animal's Effect of electroporation on wound healing skin.
Measurement of both the wound areas and wound Increasing the number of electroporative pulses breaking strength at day 7 in animals with and without from 6 to 18 attenuated the increase in transfection the administration of the most effective electroporation efficiency ( Figure 7B ).
settings (6x100 ps, 1750 V/cm), had no detrimental A low-voltage, long-duration series of pulses effect on these healing parameters. In fact, there (6 x 20 ms, 400 V/cm) was not particularly effective in was a slight nonsignificant tendency for the electroincreasing transfection efficiency with 10 gig plasmid, porated wounds to have improved healing as evidenced when compared to high-voltage, short-duration pulses by a smaller open area and greater tensile strength (6 x 100 ps, 1750 V/cm) Figure 7C . This is in contrast to ( Figure 9A and B .000 the higher doses of plasmid administered to the wounds and at greater electroporation voltages. Using "4000. The effect seen may be of considerable benefit in plasmid Injection (10 of electroporation. Six I00-ps, 1750 V/cm pulses were given with listic delivery with a gene gun, and microseeding. 3 6 an Interval of 125ms and lucIferase activity measured at 24 However, in vivo transfection efficiency with these hours (n = 4 animals per group, * p < 0.05 compared to the techniques remains several orders of magnitude less unelectroporated group, Student's t-test). efficient than that of in vitro transfection.
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Ongoing work with electroporation is being funded by plasmid into hollow visci, including blood vessels, 6 . Byrnes CK, Khan FH, Nass PH, Hatoum C, Duncan MD, Harmon JW. the lung, 3 9 and colon. 40 However, we found that in skin, Abstract. The major goal of wound healing biology is to determine how a growth factor (NGF) and epidermal growth factor (EGF), application of plasmid DNA expression vectors directly into the wound is an inefficient modality. Electroporation, the application of an electrical field across cells to permeabilize the cell membrane has led us to explore the possibility of utilizing the technique to enhance transfection effiTopical Application of Growth Factors ciency. We have identified electroporation parameters that improve the Exogenous application of growth factors to the wound site is an efficiency of DNA transfection in cutaneous wounds, and we have shown that electroporation itself does not impair wound healing. We are now on area of interest to many researchers and has been shown to have the threshold of exploring whether electroporation-assisted transfection the potential to improve wound healing [3] [4] [5] . Recombinant with DNA plasmid expression vectors for growth factors will be an PDGF (Regranex, Ortho-McNeil) has been licensed and apeffective modality for enhancing cutaneous wound healing, proved by the U.S. Food and Drug Administration as a topically applied gel that acts biologically in much the same way as endogenous PDGF by promoting the chemotactic recruitment and proliferation of cells involved in wound repair. Regranex is indicated for the treatment of diabetic neuropathic ulcers [6]. The major goal of wound healing biology is to determine how a Enhanced healing was observed with topically applied PDGF in wound can be induced to repair the damaged tissues faster and moreeffcienly.Enhncemnt f drmalandepierma reen-the clinical trial. But the effect was minimal, with a marginal more efficiently. Enhancement of dermal and epidermal regen-increase in the incidence of complete healing as compared to a eration is an extremely important goal for the treatment of many plcebge (n vs 37%). different types of wounds.
placebo gel (50% vs 37%). Wound healing occurs in multiple phases, with each phase Topical application of growth factors to wounds has major controlled by growth factors. Although each growth factor is only drawbacks; for example, in our animal study of exogenously appresent in a small amounts, they are believed to exert a powerful plied FGF-1 it was necessary to repeatedly administer large influence on wound repair. In 1986 the Nobel Prize in medicine amounts of recombinant FGF-1 to achieve a significant was awarded jointly to Rita Levi-Montalcini and Stanley Cohen improvement in wound healing [7] . Because of the short half-life for their discoveries of growth factors. They characterized nerve of the reagent, large amounts of FGF-1 were required raising the costs and complexity of its potential therapeutic use; furthermore the wound eschar can block access to the wound by growth facNorman Rich MD, FACS. in which a positive effect was noted [8] .
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With the completion of the Human Genome Sequencing Project,
6000-
the identification and cloning of potential growth factor genes
__-
yields the possibility of selectively expressing a gene at the wound site using a plasmid vector. Our group and others have previously gold beads and fired through the skin with a gene gun [11] or Effect of treatment on wound areas was used as a measure of efficacy in simply by infecting naked plasmid DNA directly to the tissue. the four experimental groups. *p < 0.05 compared to the control plasmid In our initial study [7] , we used recombinant aFGF peptide injection, (n :> 7 per group). applied topically or aFGF cDNA plasmid expression vector injected daily for 9 days into the edges of the wound. We sought to determine the effect on the wound healing rate of excisional gene delivery has high transfection efficiency, there are serious wounds made on female diabetic mice. As shown in Table 1 , concerns about its safety and potential pathogenicity [13] . The accelerated wound closure was noted in both applications. This gene gun approach provides variable results and as outlined established the feasibility of enhancing wound healing by naked earlier the large DNA load and repeated applications necessary to plasmid transfection in our hands, achieve a therapeutic effect with naked DNA approaches have Further studies, however, identified a major problem with the been shown to be disadvantageous to healing [12] . naked plasmid approach. We discovered that to achieve consisWe decided to explore the use of electroporation to improve tent transfection, high DNA plasmid load (100 pg per day) and transfection efficiency. Electroporation has been commonly used repeated penetrations of the wound by separate injections were for the delivery of DNA to cells in vitro since the early 1980s [14] . required to maintain measurable gene expression beyond two Electroporation is the application of an electrical field across cells days [12] . When we compared KGF-containing vector with a in order to permeabilize the cell membranes and allow the entry control empty DNA vector, the KGF vector was more effective at of macromolecules [15] . The applied electrical field increases accelerating wound healing [12] . However, wounded animals that transmembrane voltage potential, exceeding membrane dielectric received no injection demonstrated equivalent healing to animals strength, and creating membrane pores through which the that received KGR-bearing plasmid DNA (Fig. 1) . This study charged polynucleotide may pass [16] . The electrophoretic effect indicated that simply injecting naked DNA into the wound was of the field may also enhance DNA migration within tissues [17] . detrimental to wound healing and that both the repeated injec-In vivo electroporation has been used to increase intracellular tions and high DNA load seemed to impair wound healing, delivery of agents such as chemotherapeutics directly into tumors, and also as a means of enhancing transdermal drug delivery [16] . Alternative Transfection Strategies--Electroporation Although most commonly used for in vitro transfection applications, electroporation has been of benefit in in vivo settings as Increasing transfection efficiency may allow a reduction in the well. Improvements in the transfection of liver [18, 19] , muscle amount of DNA required to produce a clinical effect and signif- [20, 21] , tumor [22, 23] , and cutaneous tissue [24] [25] [26] [27] (Fig. 2) . We observed that electroporation growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J. Vasc. Surg 1995;21:71-78 after transfection with naked plasmid DNA offers significantly 6. Ortho-McNeil. Prescribing information for Regranex Gel. 1999;1-2 improved in vivo expression of a transfected plasmid (Fig. 3) . 
Methods
To assess plasmid transfection and wound healing, gWIZ luciferase vector and PCDNA3.1/KGF-1 expression vectors were used respectively. Cutaneous wounds were produced using a 8mm-punch biopsy in Sprague Dawley rats. Healing was impaired by cecal ligation induced sepsis. We used NIH image analysis software and histologic assessment to assess wound closure.
Results
Plasmid Transfection: EP effectively increased expression of gWIZ luciferase vector up to 53-fold compared to vector without EP (p<0.001). Transfection was localized to cutaneous tissue when plasmid injection and EP were applied to the skin with skin specific parameters.
Wound Healing: The rate of wound healing was impaired by partial cecal ligation to induce sepsis. Average wound area was 4.7 times larger on day 9 in septic rats compared to control (p<0.001). The rate of wound healing improved with PCDNA3.1/KGF-1 expression vector and
Introduction
Systemic sepsis has been shown to impair wound healing. [2] [3] [4] [5] [6] The exogenous delivery of growth factors in vivo has been demonstrated to improve wound healing. [7] [8] [9] [10] However, limitations to this technology included the requirement for frequent dosing due to the short half-life of growth factors in tissue. A longer lasting expression of growth factors can be feasibly achieved with DNA plasmid expression vectors, where a cell produces its own growth factors encoded by transfected DNA plasmids.
Previous methods of plasmid transfection in vivo faced significant barriers to clinical use for lack of transfection efficiency."'- 5 Injection of naked DNA plasmid requires prohibitively high levels of plasmid due to extremely low cell uptake efficiency. At such high concentrations, the plasmid vectors themselves interfere with wound healing.1 5 The gene gun suffers the disadvantage of producing variable results from the same gun, often requiring repeated administration to achieve a desired result. 12, 13 Adenovirus has been found to have high transfection efficiency, but at the same time it is currently under scrutiny for its potential association with the serious medical risk of producing the systemic inflammatory response syndrome.16
Electroporation (EP) has been used since the 1980's as an efficient means of plasmid transfection in vitro. 17 An electric field is applied to the cell, which is believed to create a transmembrane voltage potential that causes a disruption in the continuity of the plasma membrane.' 8 This transiently allows the passage of charged macromolecules such as negatively charged DNA plasmids. 1 9 It has been shown that an electrophoretic effect created by the applied electric field enhances the migration of DNA into cells. 20 More recently, electroporation has been used in vivo to increase intracellular delivery of chemotherapeutics directly into tumors, and to enhance transdermal drug delivery.18
Improvements in transfection of liver 21 , muscle 22 , and tumor in vivo have all been recently demonstrated using electroporation. We and others have shown that EP facilitates delivery of
DNA plasmid expression vectors to cutaneous tissue. [24] [25] [26] [27] We have demonstrated the efficacy of electroporation-assisted transfection into abnormal, injured cutaneous tissue and its potential for improving wound healing in a diabetic mouse model. 1,28
In the current study we extended our prior work by using electroporation as an in vivo method of plasmid transfection in a septic rat wound healing model. First we induced sepsis in rats via a partial cecal ligation procedure, and showed that wound healing was impaired by this procedure.
Then we used a luciferase DNA plasmid expression vector in wounded rats to assess the efficacy of electroporation-assisted naked plasmid transfection compared to transfection without electroporation. We then used the septic rat model of wound healing to determine the effect of electroporation and KGF DNA plasmid transfection on the rate of cutaneous wound closure and histologic quality of healing in the septic rat model. We also demonstrated a tissue-specific effect of electroporation-enhanced DNA plasmid delivery.
Methods
Animals
Female 6-8 week old Sprague Dawley rats were obtained from Harlan, Inc (Indianapolis, IN).
All procedures were approved by the Johns Hopkins University Animal Care and Use
Committee.
Rat Sepsis Model
For wound healing experiments, an LD20 Sprague Dawley rat sepsis model of wound healing with partial cecal ligation was utilized. 29 The rats were anesthetized with an intramuscular
injection of 50 mg/kg Ketamine. A 4 cm long mid-line incision was created in the abdomen.
The cecum was mobilized from the ascending colon. A small amount of feces was pushed into the distal portion of the cecum --enough to be trapped after ligation but not an excessive amount that would create distention and pressure. The ligation was done with Silk 2-0 at mid-portion without ligating the blood vessels. No puncture of the cecum was performed, as we found in previous experiments that this causes excessive mortality (LD80). Such a high mortality rate makes finding a measurable difference in wound healing between groups difficult. Without puncture, we produced an LD20 model, which was appropriate for these studies. The abdominal wound was closed in two layers with Ethicon 4-0. Wounds were left undressed and animals were housed individually. For the luciferase experiments, a non-septic rat model was used.
Plasmids
The Plasmid gWIZ-Luc, containing a CMV promoter and luciferase transgene, was obtained from Gene Therapy Systems (San Diego, CA). Plasmid pCDNA3.1/KGF-1 was obtained from
Invitrogen (Carlsbad, CA). Using gene specific PCR primers incorporating restriction enzyme sites for Pstl and BamH1, KGF-1 was PCR amplified from pCDNA3.1/KGF and ligated into the corresponding restriction enzyme sites in gWIZ (Gene Therapy Systems, San Diego, CA).
Plasmids were purified using an endotoxin free plasmid purification kit (Qiagen, Santa Clarita, CA) following culture in transformed DH-5a bacteria. Plasmids were stored at -70'C at a concentration of 2 mg/ml until use. 
Electroporation
Animals were electroporated at the site of injection within two minutes of plasmid administration, using a square wave electroporator (ECM 830, BTX Genetronics, San Diego, CA). A custom designed pin electrode, consisting of two 10mm rows of parallel needles separated by 5 mm was used to apply the electroporation voltage. Six square wave pulses were administered, at an amplitude of 1800 volts, 100 jis duration, with a pulse interval of 125 ms.
These EP parameters were identified as appropriate for cutaneous tissues in prior experiments. 27 In vivo Luciferase Imaging
To assess luciferase expression with and without electroporation, animals were analysed using an in vivo luciferase imaging system. In these experiments, rats were wounded and injected with plasmid as previously described, but only some groups of animals were electroporated at each transfection site using six 100ýts pulses of 1800V/cm, with an interval of 125ms, while the other group remained unelectroporated.
For the luciferase imaging, at time points after the initial transfection, animals were sedated with intraperitoneal injections of 0.025mL/g of Ketamine, and then injected intraperitoneally with 140tL of l5mg/mL of D-luciferin in PBS. After a conventional light photograph was taken, bioluminescent images were acquired using a cooled charged coupled device camera (IVIS, Xenogen, Alameda, CA). Luminescent images were taken 30 minutes following luciferin administration, during which time the light emission had been shown to be in a plateau phase. 27 Bioluminescent images were overlaid onto the conventional image of each animal, and the light emission, corrected for background luminescence, was calculated for each injection site using ( Figure 8 .) The histological grade of each wound was assigned by four blinded observers. The final score for each wound was the average score from all observers.
Statistical Analysis
Results were presented as means ± standard error of the mean (SEM). Differences in means between groups were analyzed for significance using Student's t-test or ANOVA as appropriate using SigmaStat (SYSTAT Software Inc., Point Richmond, CA).
Results
Effects of Partial Cecal Ligation on Wound Healing
To induce sepsis, partial cecal ligation was performed on experimental rats.
We found impairment of wound closure in the septic group. Average wound area was approximately 4.7 times larger on day 9 when comparing rats who underwent partial cecal ligation to control rats undergoing sham surgery (18901 +/-1636 vs. 4044.5 +/-357 pixels, respectively; p<0.001; Figure 1 ).
Luciferase Plasmid Expression Efficiency
We used the luciferase assay to determine if electroporation significantly enhanced luciferase plasmid transfection efficiency in wounded cutaneous tissue in the rat. Luciferase plasmid transfection with and without EP was compared. Rats were divided into two groups, consisting of 3 rats each. In each group six excisional wounds were created on the dorsum, three wounds on the left side and three on the right side. In both groups luciferase plasmid DNA was intradermally injected adjacent to all six wounds. DNA injection sites in the first group were not electroporated, whereas rats in the second group were electroporated at all six DNA injection sites. Comparing transfection with or without EP we observed that EP enhanced luciferase "Lin et al. -11 expression 53-fold (140,000 +/-58,000 vs. 7,520,000 +/-970,000 photons/sec, p<0.001).
( We next assessed whether the plasmid DNA expression vector remained in the cutaneous tissue or spread to the adjacent muscles of the carcass. We injected the luciferase plasmid intradermally in three places on the left dorsum of each rat with mirror image subcutaneous injections on the right. (Figure 6 .) We imaged the intact rat as before, but then dissected off the cutaneous tissue and re-imaged the strips that had been transfected after inverting them. We also imaged the dorsal musculature as seen on Figure 6 . A robust signal from the luciferase produced " Lin et al. -12 by the DNA plasmid expression vector was seen localized to the skin after intradermal injection, and this expression remained limited to the cutaneous tissue. Minimal luciferase activity was occasionally observed on the areas transfected via subcutaneous injection, for both dorsal cutaneous and dorsal muscle views. We attribute the minimal signal to possible inadvertent intradermal injection during the subcutaneous infusion.
Wound Healing
We assessed the effects of electroporation on the rate of wound healing in the septic rat model.
We had shown that wound healing is impaired in septic animals. ( In order to understand the histological effects of KGF with electroporation on wound healing, we microscopically examined wounds using the previously described grading system. We compared wound healing using KGF with EP versus KGF without EP. KGF with EP on average showed a 67% higher score than KGF without EP 
Discussion
In our experiments we showed that wound healing was impaired by sepsis. We demonstrated that the expression of DNA plasmid vectors was enhanced by electroporation. We also established that electroporation-enhanced delivery of DNA plasmid expression vectors for KGF-1 significantly improved the rate and quality of wound healing in septic rats. We showed that, using skin-specific EP parameters, transfection of DNA plasmid was localized to cutaneous tissue and did not spread to adjacent muscle.
Impaired wound healing in septic individuals remains a major unsolved problem in trauma as well as other settings. 30,1 I Rico et al. 6 showed delayed reepithelialization and collagen synthesis in the wounds of septic, cutaneously wounded mice. They found that peripheral neutrophil count was elevated in the infected animals, while the number of neutrophils and macrophages at the wound site itself was reduced. Thornton et al. 29 also found that collagen synthesis is impaired for colon anastomotic wounds in a septic rat model.
The present studies confirm the impairment in cutaneous wound healing in the rat sepsis model.
They also show that a plasmid DNA expression vector for KGF-1 delivered with electroporation can improve wound healing in this model. Both the quality of healing and the speed of closure of cutaneous wounds were improved.
Further studies using a luciferase vector confirmed that the transfection acted locally and did not spread into adjacent tissue. This is an important issue related to the potential clinical use of this modality. For clinical use it is desirable to have expression of a plasmid DNA expression vector limited to the target tissue. Our system was found to demonstrate this type of localized expression. Localized expression reduces the risk that a growth factor or other products of the delivery system will have undesirable effects on tissue remote from the wound target.
There are several potential advantages of using EP for wound healing. With EP, the concentration of plasmid required to achieve effective transfection is much lower than with naked plasmid transfection. We have previously found that the high plasmid load required to achieve transfection with naked plasmids is itself detrimental to wound healing. 15 Also, the localized nature of electroporative therapy makes it amenable to the use of local anesthesia alone. In addition, no viral vector is used, avoiding the risk of local and/or systemic inflammatory response, which may impair wound healing. Furthermore, no foreign bodies are utilized, such as with the gene gun. EP also produces less variable results than the gene gun. 12, 13 Another potential advantage of EP is that tissue specific parameters can target therapy to relatively precise locations. This, for example, would allow selective transfection of skin but not muscle, or vice versa. 24 For other purposes muscle specific parameters could be used to transfect adjacent particular muscle. It may or may not be possible to identify EP parameters that would allow direct transfection of subcutaneous tissue or the granulation tissue of the wound itself.
These approaches may have the potential to be even more effective than the present approach, and furthermore to extend the approach to improve healing beyond just cutaneous tissue.
Finally, EP itself using skin parameters is not detrimental to healing 27, as supported by the improvement in both the rate and histologic quality of healing with KGF plasmid demonstrated in our experiment.
"Lin et al. -15 For the military or civilian trauma casualty this approach has great relevance. Abdominal trauma with perforation of bowel is often complicated by sepsis. The casualty must often heal multiple other injuries to the extremities, head, and abdominal wall while sepsis is being controlled. An approach that will improve wound healing in this setting has important potential value.
Using electroporation, the DNA plasmid product, in this case KGF-1, was able to influence the 
